Suppr超能文献

一种使用人低分子量激肽原测定人尿激肽释放酶活性(激肽原酶活性)的简单灵敏方法。

A simple and sensitive method for determination of human urinary kallikrein activity (kininogenase activity), using human low molecular weight kininogen.

作者信息

Kondo M, Shimamoto K, Ura N, Nishimiya T, Mita T, Nakagawa M, Maeda T, Yamaguchi Y, Iimura O

出版信息

Endocrinol Jpn. 1984 Oct;31(5):635-43. doi: 10.1507/endocrj1954.31.635.

Abstract

Human low molecular weight kininogen was partially purified and applied to the measurement of human glandular kallikrein as a substrate. The prepared human low molecular weight kininogen did not contain any significant amounts of kinin generating or destroying enzymes. When ethanol was added to the assay tube to stop the enzyme reaction, the substrate was almost completely removed from the incubation solution. Moreover, less than 1.25% ethanol had no effect on the kinin radioimmunoassay. These data suggest that the measurement of generated kinin can be done directly after the addition of ethanol. In this assay system, control tubes were unnecessary since the small volume of the urine samples (0.5 to 2.0 nl) contained negligible amounts of endogenous kinin. In a comparison of the availability as a substrate for human urinary kallikrein among human, dog and bovine low molecular weight kininogens, the enzyme activity was 5 or 100 times as high in the human substrate as in the dog and bovine substrates, suggesting that a human substrate is best for the human enzyme. A significant correlation was found between our previous method using bovine substrate and this method for human urinary kallikrein activity. In both methods, urinary kallikrein excretions were significantly lower in patients with essential hypertension and higher in those with primary aldosteronism, respectively. This simple, specific and sensitive kininogenase assay system seems to be very useful for investigating the physiological or pathophysiological role of the renal kallikrein-kinin system in hypertensive and renal diseases.

摘要

人低分子量激肽原被部分纯化,并用作底物来测定人腺体激肽释放酶。所制备的人低分子量激肽原不含有任何大量的激肽生成或破坏酶。当向测定管中加入乙醇以终止酶反应时,底物几乎完全从孵育溶液中去除。此外,低于1.25%的乙醇对激肽放射免疫测定没有影响。这些数据表明,加入乙醇后可直接测定生成的激肽。在该测定系统中,由于尿液样本量小(0.5至2.0纳升),内源性激肽含量可忽略不计,因此无需设置对照管。在比较人、狗和牛的低分子量激肽原作为人尿激肽释放酶底物的可用性时,人底物中的酶活性分别比狗和牛底物中的高5倍或100倍,这表明人底物对人酶最适用。我们之前使用牛底物的方法与该人尿激肽释放酶活性方法之间存在显著相关性。在这两种方法中,原发性高血压患者的尿激肽释放酶排泄量均显著降低,而原发性醛固酮增多症患者的尿激肽释放酶排泄量均显著升高。这种简单、特异且灵敏的激肽原酶测定系统似乎对研究肾激肽释放酶-激肽系统在高血压和肾脏疾病中的生理或病理生理作用非常有用。

相似文献

3
Measurement of urinary kallikrein acitvity by kinin radioimmunoassay.
Jpn Circ J. 1979 Mar;43(3):147-52. doi: 10.1253/jcj.43.147.
5
Components of the kallikrein-kinin system in rat urine.
Biochem Pharmacol. 1984 Jun 1;33(11):1779-82. doi: 10.1016/0006-2952(84)90349-6.
8
The role of urinary kininogen in the regulation of kinin generation.
Kidney Int. 1985 Dec;28(6):975-81. doi: 10.1038/ki.1985.226.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验